Introduction Leishmaniasis is an important disease caused by parasites of the Leishmania.
Due to the urgent need for financial incentives and research and development of new anti …

Visceral leishmaniasis (VL) is a fatal vector-borne parasitic syndrome attributable to the
protozoa of the Leishmania donovani complex. The available chemotherapeutic options are …

Introduction: The parenteral administration of pentavalent antimonials for the treatment of all
forms of leishmaniasis, including cutaneous leishamniasis (CL), has several limitations …

Leishmaniasis corresponds to a group of neglected tropical diseases caused by flagellated
protozoa belonging to the Leishmania genus. This widely spread illness is found in over 90 …

Leishmaniasis is a worldwide disease that leads to high mortality and morbidity in human
populations. Today, leishmaniasis is managed via drug therapy. The drugs that are already …

Leishmaniasis is one of the most important tropical neglected diseases according to the
World Health Organization. Even after more than a century, we still have few drugs for the …

Macrophage-specific delivery systems are the subject of much interest nowadays, because
of the fact that macrophages act as host cells for many parasites and bacteria, which give …

Introduction: Cutaneous and mucocutaneous leishmaniasis are major tropical skin diseases.
Topical treatment is currently limited to the least severe forms of cutaneous leishmaniasis …

Leishmaniasis, a vector-borne disease caused by obligate intramacrophage protozoa,
threatens 350 million people in 98 countries around the world. There are already 12 million …

Considered prevalent in many countries on five continents, especially in low‐income
regions, leishmaniasis is a neglected tropical disease classified by World Health …